Literature DB >> 26015549

Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion.

Ele Ferrannini1, Stefania Camastra2, Brenno Astiarraga2, Monica Nannipieri2, Jose Castro-Perez3, Dan Xie3, Liangsu Wang3, Manu Chakravarthy3, Rebecca A Haeusler4.   

Abstract

Biliopancreatic diversion (BPD) improves insulin sensitivity and decreases serum cholesterol out of proportion with weight loss. Mechanisms of these effects are unknown. One set of proposed contributors to metabolic improvements after bariatric surgeries is bile acids (BAs). We investigated the early and late effects of BPD on plasma BA levels, composition, and markers of BA synthesis in 15 patients with type 2 diabetes (T2D). We compared these to the early and late effects of Roux-en-Y gastric bypass (RYGB) in 22 patients with T2D and 16 with normal glucose tolerance. Seven weeks after BPD, insulin sensitivity had doubled and serum cholesterol had halved. At this time, BA synthesis markers and total plasma BAs, particularly unconjugated BAs, had markedly risen; this effect could not be entirely explained by low FGF19. In contrast, after RYGB, insulin sensitivity improved gradually with weight loss and cholesterol levels declined marginally; BA synthesis markers were decreased at an early time point (2 weeks) after surgery and returned to the normal range 1 year later. These findings indicate that BA synthesis contributes to the decreased serum cholesterol after BPD. Moreover, they suggest a potential role for altered enterohepatic circulation of BAs in improving insulin sensitivity and cholesterol metabolism after BPD.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26015549      PMCID: PMC4587641          DOI: 10.2337/db15-0214

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

1.  Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.

Authors:  Lihong Chen; Xiaozhou Yao; Andrew Young; Judi McNulty; Don Anderson; Yaping Liu; Christopher Nystrom; Dallas Croom; Sean Ross; Jon Collins; Deepak Rajpal; Kimberly Hamlet; Chari Smith; Bronislava Gedulin
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-20       Impact factor: 4.310

2.  Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation.

Authors:  Nicola Scopinaro
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

3.  Are bile acids the new gut hormones? Lessons from weight loss surgery models.

Authors:  D J Pournaras; C W le Roux
Journal:  Endocrinology       Date:  2013-07       Impact factor: 4.736

4.  Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy.

Authors:  L Garrido-Sanchez; M Murri; J Rivas-Becerra; L Ocaña-Wilhelmi; R V Cohen; E Garcia-Fuentes; F J Tinahones
Journal:  Surg Obes Relat Dis       Date:  2011-03-31       Impact factor: 4.734

5.  Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

Authors:  C Beysen; E J Murphy; K Deines; M Chan; E Tsang; A Glass; S M Turner; J Protasio; T Riiff; M K Hellerstein
Journal:  Diabetologia       Date:  2011-12-02       Impact factor: 10.122

6.  Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.

Authors:  Bo Kong; Li Wang; John Y L Chiang; Youcai Zhang; Curtis D Klaassen; Grace L Guo
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

7.  The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control.

Authors:  Dimitri J Pournaras; Clare Glicksman; Royce P Vincent; Shophia Kuganolipava; Jamie Alaghband-Zadeh; David Mahon; Jan H R Bekker; Mohammad A Ghatei; Stephen R Bloom; Julian R F Walters; Richard Welbourn; Carel W le Roux
Journal:  Endocrinology       Date:  2012-06-06       Impact factor: 4.736

8.  Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

Authors:  Rohit Kohli; David Bradley; Kenneth D Setchell; J Christopher Eagon; Nada Abumrad; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

Review 9.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

10.  Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures.

Authors:  Alberto Benetti; Marina Del Puppo; Andrea Crosignani; Annamaria Veronelli; Enzo Masci; Francesca Frigè; Giancarlo Micheletto; Valerio Panizzo; Antonio E Pontiroli
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

View more
  30 in total

Review 1.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

2.  Obesity diabetes and the role of bile acids in metabolism.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  J Transl Int Med       Date:  2016-07-07

Review 3.  Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?

Authors:  M Chondronikola; L L S Harris; S Klein
Journal:  J Intern Med       Date:  2016-10-14       Impact factor: 8.989

4.  γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery.

Authors:  Maria Franzini; Veronica Musetti; Daniela Guarino; Laura Caponi; Aldo Paolicchi; Michele Emdin; Ele Ferrannini; Monica Nannipieri
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

5.  Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs.

Authors:  O Chávez-Talavera; G Baud; V Spinelli; M Daoudi; M Kouach; J-F Goossens; E Vallez; R Caiazzo; M Ghunaim; T Hubert; S Lestavel; A Tailleux; B Staels; F Pattou
Journal:  Int J Obes (Lond)       Date:  2017-01-17       Impact factor: 5.095

Review 6.  Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.

Authors:  Matthew G Browning; Bernardo M Pessoa; Jad Khoraki; Guilherme M Campos
Journal:  Curr Obes Rep       Date:  2019-06

7.  Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model.

Authors:  Xiang Zhang; Yanmin Wang; Mingwei Zhong; Teng Liu; Haifeng Han; Guangyong Zhang; Shaozhuang Liu; Meng Wei; Qunzheng Wu; Sanyuan Hu
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

8.  Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial.

Authors:  Reza Nemati; Jun Lu; Dech Dokpuang; Michael Booth; Lindsay D Plank; Rinki Murphy
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

9.  Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity.

Authors:  Rebecca A Haeusler; Stefania Camastra; Monica Nannipieri; Brenno Astiarraga; Jose Castro-Perez; Dan Xie; Liangsu Wang; Manu Chakravarthy; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2015-12-18       Impact factor: 5.958

10.  Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.

Authors:  Lydia-Ann L S Harris; Gordon I Smith; Bettina Mittendorfer; J Christopher Eagon; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.